US 12144826
Methods of treating EGFRvIII expressing glioblastomas
granted A61KA61K2039/507A61K2039/585
Quick answer
US patent 12144826 (Methods of treating EGFRvIII expressing glioblastomas) held by The Regents of the University of California expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/507, A61K2039/585, A61K2239/31, A61K2239/38